Cannabinoids

is the President and Founder, jCanna, Inc. and Cannabis Science Conference. He is also a contributing editor for Cannabis Science & Technology.

Articles

A review on a handful of recent articles related to COVID-19 and cannabis as well as an interview with a top medical cannabis expert—Dr. Prakash Nagarkatti.

A Storm of Research Activity into Cannabis and Coronavirus A Closer Look at Expanding Research of Cannabinoids and Terpenes in COVID-19

Op-ed on a new study related to how cannabidiol (CBD) exerts its clinical efficacy.

New Study Links Cannabidiol’s Multitudinous Effects to Disruption of Cholesterol Homeostasis

Ric Cuchetto discusses the technology behind THC remediation and some of the challenges it presents.

THC Remediation: A Basic Understanding

This article explores the pros and cons of grinding cannabis prior to extraction along with the effects of particle size.

To Grind or Not To Grind

An interview with Dr. Bonni Goldstein on treating patients during a pandemic, telemedicine, cannabis research, and more.

Treating Immunocompromised Patients During the COVID-19 Pandemic:  A Conversation with Dr. Bonni Goldstein

A rapid LC–MS/MS method is presented for the quantitative analysis of 16 cannabinoids in hemp samples with a single dilution protocol.

Rapid Analysis of 16 Major and Minor Cannabinoids in Hemp Using LC–MS/MS with a Single Sample Dilution and Injection

is a Senior Scientist at Agilent Technologies and a Visiting Professor at The Johns Hopkins University School of Medicine in Baltimore, Maryland.

This article focuses on the use of GC–MS for the analysis of derivatized cannabinoids in hempseed oil matrix.

A Brief Review of Derivatization Chemistries for the Analysis of Cannabinoids Using GC–MS

A review of the chemical makeup of cannabis extracts and how they affect the human body. From terpenes to cannabinoids, this article takes a deep dive into the chemistry of cannabis extracts.

Exploring the Chemical Makeup of Cannabis Extract by Method

An interview with an amazing family of four doctors—the Knox Docs—who are key opinion leaders in cannabis therapeutics, endocannabinology, and cannabinoid medicine.

The First Family of Cannabinoid Medicine: The Knox Docs

A closer look at some of the current in vitro evidence suggesting that cannabinoids possess potent activity against a range of gram-positive bacteria.